We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Cell line development (CLD) on the Beacon® optofluidic system enables selection of the best production cell lines with >99% monoclonality assurance in just days. The new Opto™ CLD 2.0 workflow extends these capabilities to allow (1) enrichment of rare cell populations, (2) on-chip titer measurements for traditional and non-traditional antibody molecules, and (3) efficient recovery of top clones for scale-up.